Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Entresto Tablets and Granules for Pediatric Specified Drug-use Survey (Pediatric Chronic Heart Failure) |
Pediatric Chronic Heart Failure | Japan | NCT06659393 | |
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia |
Familial Hypercholesterolemia - Heterozygous | Phase3 | Argentina Austria Belgium Brazil China Czechia France Germany Greece Hong Kong Hungary Israel Italy Malaysia Netherlands Poland Portugal South Africa Spain Taiwan Turkey (Türkiye) United Kingdom United States View all |
NCT06597019 |
An Open-label Study to Assess the Safety, Efficacy, and Cellular Kinetics of YTB323 in Relapsing Multiple Sclerosis |
Relapsing Multiple Sclerosis | Phase1, Phase2 | Australia France Germany Italy Spain Switzerland View all |
NCT06617793 |
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS |
Relapsing Remitting Multiple Sclerosis (RRMS) | Phase4 | Canada | NCT06733922 |
A Study of Radiation Dosimetry, Safety, and Tolerability of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment in Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer: RADIOpharmaceutical DOSimetry Evaluation (RADIODOSE) Study |
Metastatic Castration-Resistant Prostate Cancer | Phase1 | Germany Netherlands Spain Switzerland United Kingdom United States View all |
NCT06531499 |
Phase 2 Study of Rapcabtagene Autoleucel in Myositis |
Idiopathic Inflammatory Myopathies | Phase2 | France Germany Israel Italy Japan Netherlands Saudi Arabia Singapore Spain Switzerland Taiwan United Kingdom United States View all |
NCT06665256 |
Specified Drug-use Surveillance of Fabhalta Capsules |
Paroxysmal Nocturnal Hemoglobinuria | Japan | NCT06606314 | |
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B) |
Healthy Volunteers, Pulmonary Arterial Hypertension | Phase1, Phase2 | Australia Brazil Czechia Germany Greece Italy Latvia Portugal Romania Spain United Kingdom United States View all |
NCT06649110 |
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). |
Systemic Lupus Erythematosus, SLE | Phase1 | China Germany Hungary Netherlands Spain Switzerland View all |
NCT06335979 |
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE) |
Sickle Cell Disease | Phase3 | Brazil Colombia Kenya United States View all |
NCT06439082 |